Chlorhexidine and Hypersensitivity Reactions in Dentistry

Total Page:16

File Type:pdf, Size:1020Kb

Chlorhexidine and Hypersensitivity Reactions in Dentistry Chlorhexidine and IN BRIEF • Describes the history of chlorhexidine use in medicine and dentistry. PRACTICE hypersensitivity reactions • Highlights the spectrum of reported hypersensitivity reactions to chlorhexidine. • Reports two cases of death due to in dentistry anaphylaxis following the use of chlorhexidine in post-extraction tooth M. N. Pemberton1 and J. Gibson2 socket care. VERIFIABLE CPD PAPER Immunological reactions to chlorhexidine, including allergy (Type I hypersensitivity) and allergic contact dermatitis/stoma‑ titis (Type IV hypersensitivity), have been recognised for many years. This potential safety issue, however, is not well known within dentistry. The purpose of this paper is to alert dentists and dental care professionals to the potential of chlorhex‑ idine in causing hypersensitivity reactions and to consider this possibility if unexplained hypersensitivity reactions occur. INTRODUCTION skin creams and disinfectants used to pre- Table 1 Mild allergy – signs, symptoms and management13 In the 1970s, seminal studies on the value pare the skin for surgical procedures. In the of chlorhexidine mouthwash in the control early 1990s, chlorhexidine also began to be Key symptoms and signs of mild allergy of plaque and gingivitis were undertaken.1,2 incorporated into the composition of medi- Urticaria and rash, particularly of chest, Following these studies, 0.1‑0.2% chlorhex- cal devices including intravenous catheters, hands and feet idine mouthwash has become a frequently topical antimicrobial skin dressings and Rhinitis, conjunctivitis 4 recommended or prescribed treatment in implanted antimicrobial surgical mesh. No difficulty breathing the management of gingivitis. Studies have From use in all of these medical applica- Key management principles of mild allergy shown its benefit over other potentially use- tions, it has become apparent that chlo- ful plaque inhibiting agents and indicated rhexidine has the potential to produce Assess the patient specific situations in which chlorhexidine hypersensitivity reactions. Hypersensitivity Give oral antihistamine (for example, chlorphena‑ is of particular benefit.3 As well as being reactions are generally known to occur in mine 4 mg tablet or loratadine 10 mg tablet in adults. Refer to BNF or BNFC available in a mouthwash form, chlorhex- four main forms, I–IV, with Type I (imme- for child doses) idine is also available in other vehicles for diate and mediated chiefly by immuno- Reassess the patient. If severe reaction use in oral healthcare including toothpastes, globulin E) and Type IV (delayed and developing, treat as for anaphylaxis sprays and gels. Common side effects, such mediated by the cells of the immune sys- Refer patient to their general medical practitioner as staining of teeth are well recognised; tem) being the reactions of greatest con- however, rarer, but potentially more severe cern in the orofacial region. side effects including hypersensitivity, are The Type IV hypersensitivity reaction manage mild Type 1 hypersensitivity (aller- less well known. of contact dermatitis to chlorhexidine has gic) reactions and anaphylaxis are given in been reported in both adults and children Tables 1 and 2.12,13 The true prevalence of CHLORHEXIDINE HYPERSENSITIVITY with confirmation by patch testing in many these reactions remains unknown. In the AND MEDICAL PRODUCTS cases.5–7 This delayed type of hypersensi- medical literature, reactions have mainly For many years, chlorhexidine-containing tivity has most frequently followed the been recorded in case reports with these products have also been used in other areas use of chlorhexidine-containing topical cases falling into three broad categories.14 of medicine because of chlorhexidine’s medicinal creams used to treat inflamed Type I hypersensitivity reactions have beneficial effects as a topical antimicrobial skin. It has also followed the use of cos- been reported when chlorhexidine has agent. These products include antiseptic metic products containing chlorhexidine. been applied to damaged skin surfaces.8,10,14 Type I hypersensitivity reactions These instances include wounds and burns 1*Consultant in Oral Medicine and Honorary Lecturer, have been reported especially where or when the skin was cut in surgical pro- University Dental Hospital of Manchester and School of Dentistry, Higher Cambridge Street, Manchester, M15 chlorhexidine has been used topically, cedures and a chlorhexidine containing 6FH; 2Consultant and Honorary Senior Lecturer in Oral intra-urethrally, and with chlorhexidine- product had been used in the prepara- Medicine, Department of Oral Medicine, Dundee Dental Hospital & School, Dundee, DD1 4HN impregnated catheters. Incidents of this tion of the skin. Anaphylactic reactions *Correspondence to: Michael Pemberton immediate allergic type of hypersensitiv- have been reported. There have also been Email: [email protected] ity have been reported from all over the a few cases in which chlorhexidine use on Refereed Paper world, with the reactions reported ranging unbroken skin has also led to immediate Accepted 10 October 2012 14 DOI: 10.1038/sj.bdj.2012.1086 from localised urticaria to life-threatening type hypersensitivity reactions. These ©British Dental Journal 2012; 213: 547-550 anaphylactic shock.8–11 Details of how to include when chlorhexidine has been BRITISH DENTAL JOURNAL VOLUME 213 NO. 11 DEC 8 2012 547 © 2012 Macmillan Publishers Limited. All rights reserved. PRACTICE applied to pre-existing hand dermatitis, early 1970s, many studies were carried Table 2 Anaphylaxis – signs, symptoms acne or to erythematous skin. out looking at the utility of chlorhex- and management12,13 Type I hypersensitivity reactions, includ- idine mouthwash as part of dental care. Key symptoms and signs of anaphylaxis ing anaphylaxis, have been reported when Radiolabelling of chlorhexidine was used may include chlorhexidine has been applied to mucous to identify the retention and distribu- Facial flushing, swelling and paraesthesia membranes.11,14–16 In the majority of cases, tion of 10 ml of a chlorhexidine 0.2% Generalised urticaria or itching these have been associated with chlo- mouthwash used in healthy volunteers. It rhexidine-containing gels and lubricants was found that an average of 4% of the Wheezing, stridor or difficulty breathing inserted into the urethra before catheteri- compound was swallowed by the adults Abdominal pain sation or cystoscopy. Other cases have been studied and an average of 30% retained Sense of impending doom reported following chlorhexidine lubricant in the mouth.19 There was a rapid fall in applied intra-vaginally before gynaeco- the chlorhexidine concentration found Rapid, weak or impalpable pulse logical examination and chlorhexidine- in the mouth over the first few hours, Falling blood pressure containing ophthalmic wash solution. but with some activity still present after Type I hypersensitivity reactions have 24 hours. While chlorhexidine appeared Key management principles of anaphylaxis been reported when chlorhexidine has to be a poorly absorbed drug, radiola- Assess the patient using an ABCDE approach been impregnated into central venous belled chlorhexidine was detected in the Call ambulance catheters.14,17,18 In 1996, such catheters kidney and liver in animal studies, indi- 20 Secure the airway and give 100% oxygen were introduced into practice and within cating some absorption had occurred. In (10‑15 litres per minute flow rate) the next few years, there were reports of 1971, a study looked at the side effects of Lay patient flat and raise legs to support patients experiencing anaphylactic-like chlorhexidine mouthwashes in a group of blood pressure 21 adverse effects. Reports came from sev- 50 soldiers over a period of four months. Administer 0.5 ml of 1:1000 adrenaline eral countries, but the majority were from The study found some cases where chlo- (adrenaline) in adults via intramuscular Japan. It is not clear why the majority of rhexidine mouthwash caused irritation injection and repeat at 5 minute intervals if needed. (For children, child 6‑12 years give these reactions occurred in the Japanese and damage to the oral mucosa with 0.3 ml of 1:1000 adrenaline, child less than population. Possible explanations include resultant chemically-induced trauma. The 6 years give 0.15 ml of 1:1000 adrenaline) a genetic predisposition or an increased frequency of this side effect appeared to Monitor patient and if cardiac arrest occurs, start exposure to chlorhexidine-containing increase with increasing chlorhexidine basic life support immediately products resulting in heightened sensitiv- concentration. ity. The catheter was subsequently with- In the early 1970s, no cases of sensitisa- shortly after an upper lip injury was dis- drawn from use in Japan, and the United tion to chlorhexidine used in the mouth infected with 0.05% chlorhexidine gluco- States Food and Drug Administration had yet been observed.21 Since then, immu- nate.16 The patient subsequently showed a issued an alert concerning potential hyper- nological reactions to chlorhexidine when positive response to an intra-dermal test. sensitivity reactions to chlorhexidine- used in the mouth have been infrequently Recently we have become aware of impregnated medical devices.4,17 The alert documented in the medical and dental liter- two cases of anaphylaxis in the UK, recommended that if a patient exhibited ature. Allergic contact stomatitis (Type IV thought to be triggered by chlorhexidine an unexplained hypersensitivity
Recommended publications
  • Hypersensitivity Reactions (Types I, II, III, IV)
    Hypersensitivity Reactions (Types I, II, III, IV) April 15, 2009 Inflammatory response - local, eliminates antigen without extensively damaging the host’s tissue. Hypersensitivity - immune & inflammatory responses that are harmful to the host (von Pirquet, 1906) - Type I Produce effector molecules Capable of ingesting foreign Particles Association with parasite infection Modified from Abbas, Lichtman & Pillai, Table 19-1 Type I hypersensitivity response IgE VH V L Cε1 CL Binds to mast cell Normal serum level = 0.0003 mg/ml Binds Fc region of IgE Link Intracellular signal trans. Initiation of degranulation Larche et al. Nat. Rev. Immunol 6:761-771, 2006 Abbas, Lichtman & Pillai,19-8 Factors in the development of allergic diseases • Geographical distribution • Environmental factors - climate, air pollution, socioeconomic status • Genetic risk factors • “Hygiene hypothesis” – Older siblings, day care – Exposure to certain foods, farm animals – Exposure to antibiotics during infancy • Cytokine milieu Adapted from Bach, JF. N Engl J Med 347:911, 2002. Upham & Holt. Curr Opin Allergy Clin Immunol 5:167, 2005 Also: Papadopoulos and Kalobatsou. Curr Op Allergy Clin Immunol 7:91-95, 2007 IgE-mediated diseases in humans • Systemic (anaphylactic shock) •Asthma – Classification by immunopathological phenotype can be used to determine management strategies • Hay fever (allergic rhinitis) • Allergic conjunctivitis • Skin reactions • Food allergies Diseases in Humans (I) • Systemic anaphylaxis - potentially fatal - due to food ingestion (eggs, shellfish,
    [Show full text]
  • Delayed-Type Hypersensitivity Reaction to Measure Cellular Immune Responses in RNA-SARS-Cov-2 Vaccinated Individuals
    Communication The Beauty of Simplicity: Delayed-Type Hypersensitivity Reaction to Measure Cellular Immune Responses in RNA-SARS-Cov-2 Vaccinated Individuals Yvelise Barrios 1, Andres Franco 1, Inmaculada Sánchez-Machín 2, Paloma Poza-Guedes 2, Ruperto González-Pérez 2 and Victor Matheu 2,* 1 Department of Immunology, Hospital Universitario de Canarias, 38320 San Cristóbal de La Laguna, Spain; [email protected] (Y.B.); [email protected] (A.F.) 2 Department of Allergy, Hospital Universitario de Canarias, 38320 San Cristóbal de La Laguna, Spain; [email protected] (I.S.-M.); [email protected] (P.P.-G.); [email protected] (R.G.-P.) * Correspondence: [email protected] Abstract: Background: Monitoring cellular immune responses elicited in vaccinated individuals is highly complicated. Methods: 28 individuals participated during the vaccination process with 12 BNT162b2 mRNA (Pfizer) vaccine. Specific anti-RBD IgG using a classic ELISA was performed in days 10 and 20 (after one dose of the vaccine) and on day 35 (after two vaccine doses) in serum samples of all participants. In parallel, DTH (delayed-type hypersensitivity) Skin Test using S protein was performed before (11/28) and after two doses (28/28) of the vaccine. Results: 6/28 individuals Citation: Barrios, Y.; Franco, A.; were considered positive for the specific anti-RBD IgG positive at day 10, whereas all 28 individuals Sánchez-Machín, I.; Poza-Guedes, P.; were positive at day 20. Moreover, 28/28 individuals increased the OD ratios at day 36 (2 doses). González-Pérez, R.; Matheu, V. The DTH cutaneous test was performed on 11/28 participants at day 20 (1 dose) showing 8/11 a positive Beauty of Simplicity: Delayed-Type Hypersensitivity Reaction to Measure reaction at 12 h.
    [Show full text]
  • Hypersensitivity Reaction Types
    put together by Alex Yartsev: Sorry if i used your images or data and forgot to reference you. Tell me who you are. [email protected] ypersensitivity Reactions ripped shamelessly fffrfrrromom a website which can no longer be recalled Type I - immediate hypersensitivity Mediated by IgE antibodies and produced by the immediate release of histamine, arachidonate and derivatives by basophils and mast cells. This causes an inflammatory response leading to an immediate (within seconds to minutes) reaction. Some examples: • Allergic asthma • Allergic conjunctivitis • Allergic rhinitis ("hay fever") • Anaphylaxis • Angioedema • Urticaria (hives) Type II - antibody-dependent hypersensitivity In type II hypersensitivity, the antibodies produced by the immune response bind to antigens on the patient's own cell surfaces. IgG and IgM antibodies bind to these antigens to form complexes that activate the classical pathway of complement activation for eliminating cells presenting foreign antigens (which are usually, but not in this case, pathogens). That is, mediators of acute inflammation are generated at the site and membrane attack complexes cause cell lysis and death. The reaction takes hours to a day. Some examples: • Autoimmune haemolytic anaemia • Goodpasture's syndrome • Pemphigus • Pernicious anemia • Immune thrombocytopenia • Transfusion reactions Type III - immune complex hypersensitivity In type III hypersensitivity, soluble immune complexes (aggregations of antigens and IgG and IgM antibodies) form in the blood and are deposited
    [Show full text]
  • Hypersensitivity Reactions to Monoclonal Antibodies: Classification and Treatment Approach (Review)
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 22: 949, 2021 Hypersensitivity reactions to monoclonal antibodies: Classification and treatment approach (Review) IRENA PINTEA1,2*, CARINA PETRICAU1,2, DINU DUMITRASCU3, ADRIANA MUNTEAN1,2, DANIEL CONSTANTIN BRANISTEANU4*, DACIANA ELENA BRANISTEANU5* and DIANA DELEANU1,2,6 1Allergy Department, ‘Professor Doctor Octavian Fodor’ Regional Institute of Gastroenterology and Hepatology; 2Allergology and Immunology Discipline, 3Anatomy Discipline, ‘Iuliu Hatieganu’ University of Medicine and Pharmacy, 400000 Cluj‑Napoca; Departments of 4Ophthalmology and 5Dermatology, ‘Grigore T. Popa’ University of Medicine and Pharmacy, 700115 Iasi; 6Internal Medicine Department, ‘Professor Doctor Octavian Fodor’ Regional Institute of Gastroenterology and Hepatology, 400000 Cluj‑Napoca, Romania Received February 16, 2021; Accepted March 18, 2021 DOI: 10.3892/etm.2021.10381 Abstract. The present paper aims to review the topic of adverse Contents reactions to biological agents, in terms of the incriminating mechanisms and therapeutic approach. As a result of immuno‑ 1. Introduction modulatory therapy, the last decade has achieved spectacular 2. Adverse reactions to monoclonal antibodies: Classification results in the targeted treatment of inflammatory, autoimmune, 3. Therapeutic approach: Rapid drug desensitization and neoplastic diseases, to name a few. The widespread use of 4. Conclusions biological agents is, however, associated with an increase in the number of observed adverse drug reactions ranging from local erythema
    [Show full text]
  • Diseases of the Immune System 813
    Chapter 19 | Diseases of the Immune System 813 Chapter 19 Diseases of the Immune System Figure 19.1 Bee stings and other allergens can cause life-threatening, systemic allergic reactions. Sensitive individuals may need to carry an epinephrine auto-injector (e.g., EpiPen) in case of a sting. A bee-sting allergy is an example of an immune response that is harmful to the host rather than protective; epinephrine counteracts the severe drop in blood pressure that can result from the immune response. (credit right: modification of work by Carol Bleistine) Chapter Outline 19.1 Hypersensitivities 19.2 Autoimmune Disorders 19.3 Organ Transplantation and Rejection 19.4 Immunodeficiency 19.5 Cancer Immunobiology and Immunotherapy Introduction An allergic reaction is an immune response to a type of antigen called an allergen. Allergens can be found in many different items, from peanuts and insect stings to latex and some drugs. Unlike other kinds of antigens, allergens are not necessarily associated with pathogenic microbes, and many allergens provoke no immune response at all in most people. Allergic responses vary in severity. Some are mild and localized, like hay fever or hives, but others can result in systemic, life-threatening reactions. Anaphylaxis, for example, is a rapidly developing allergic reaction that can cause a dangerous drop in blood pressure and severe swelling of the throat that may close off the airway. Allergies are just one example of how the immune system—the system normally responsible for preventing disease—can actually cause or mediate disease symptoms. In this chapter, we will further explore allergies and other disorders of the immune system, including hypersensitivity reactions, autoimmune diseases, transplant rejection, and diseases associated with immunodeficiency.
    [Show full text]
  • 3-Autoimmune Disorders
    Autoimmune Disorders: Light at the End of the Tunnel? Autoimmunity, one of three major mechanisms of ‘inappropriate’ immunity What are autoimmune diseases? The ability of the immune system to discriminate between ‘self’ and ‘non-self’ is a fundamental requirement for life. The existence of self-tolerance prevents the individual’s immune system from attacking normal cells and tissues of the body. A breakdown or failure of the mechanisms of self- tolerance results in Autoimmunity. Our bodies have an immune system, which is a complex network of special cells and organs that defends the body from germs and other foreign invaders. At the core of the immune system is the ability to tell the difference between self and nonself: what's you and what's foreign. A flaw can make the body unable to tell the difference between self and nonself. When this happens, the body makes autoantibodies that attack normal cells by mistake. At the same time special cells called regulatory T cells fail to do their job of keeping the immune system in line. The result is a misguided attack on your own body. This causes the damage we know as autoimmune disease. The body parts that are affected depend on the type of autoimmune disease. There are more than 80 known types. Autoimmune Diseases In autoimmunity, an immune response to self results in tissue injury. Autoimmune disorders are a diverse group of conditions, which occur due to abnormal stimulation and signaling within the immune system. "Self" versus "non-self" recognition is altered. • There are ~80 different autoimmune diseases.
    [Show full text]
  • Immunopathology Jeffrey S
    91731_ch04 12/8/06 7:38 PM Page 99 Built By: jerry/CHEY QC’ed By: Corrected By: LP-QPC-91731 Chapter 4 Please Delete Before Going to Printer 4 Immunopathology Jeffrey S. Warren Douglas P. Bennett Roger J. Pomerantz Biology of the Immune System Combined Immunodeficiency Diseases Cellular Components of the Immune System Wiskott-Aldrich Syndrome The Major Histocompatibility Complex (MHC) Autoimmunity and Autoimmune Diseases Integrated Cellular and Humoral Immune Responses Autoimmune Disease and Immunologic Tolerance Clinical Evaluation of Immune Status Systemic Lupus Erythematosus (SLE) Immunoglobulin Concentrations Lupus-like Diseases Antibody-Dependent Immunity Sjögren Syndrome Cell-Mediated Immunity Scleroderma (Progressive Systemic Sclerosis) Lymphocyte Populations Mixed Connective Tissue Disease Molecular Diagnostic Studies Immune Reactions to Transplanted Tissues AQ1 Immunologically Mediated Tissue Injury Hyperacute Rejection AU 1 IgE-Mediated Immediate Hypersensitivity Reactions Acute Rejection AU 2 AU 6 (Type I) Chronic Rejection AQ3 AU 3 Non–IgE Antibody-Mediated Hypersensitivity Reaction Graft-versus-Host Disease AU 4 (Type II) Human Immunodeficiency Virus (HIV) Infection and Cell-Mediated Immune Complex Reactions (Type III) Acquired Immunodeficiency Syndrome (AIDS) AU 7 Hypersensitivity Reactions (Type IV) Transmission AQ4 Immunodeficiency Diseases HIV-1 Primary Antibody Deficiency Diseases Opportunistic Infections Primary T Cell Immunodeficiency Diseases HIV-2 AQ2AU 5 he most basic challenge to an organism is to distinguish self Chapter 2). Host defenses that are not antigen-specific are called from nonself so that it can continue to exist. The chief role the “innate” immune system. Antigen-specific or “adaptive” Tof the immune system is to protect the host from invasion immune system encompasses lymphocytes, plasma cells, anti- by foreign agents.
    [Show full text]
  • Hypersensitivity - Clinicalkey
    Hypersensitivity - ClinicalKey https://www.clinicalkey.com/#!/content/book/3-s2.0-B978032339... BOOK CHAPTER Hypersensitivity Abul K. Abbas MBBS, Andrew H. Lichtman MD, PhD and Shiv Pillai MBBS, PhD Basic Immunology: Functions and Disorders of the Immune System, Chapter 11, 231-247 The concept that the immune system is required for defending the host against infections has been emphasized throughout this book. However, immune responses are themselves capable of causing tissue injury and disease. Injurious, or pathologic, immune reactions are called hypersensitivity reactions. An immune response to an antigen may result in sensitivity to challenge with that antigen, and therefore hypersensitivity is a reflection of excessive or aberrant immune responses. Hypersensitivity reactions may occur in two situations. First, responses to foreign antigens (microbes and noninfectious environmental antigens) may cause tissue injury, especially if the reactions are repetitious or poorly controlled. Second, the immune responses may be directed against self (autologous) antigens, as a result of the failure of self-tolerance (see Chapter 9 ). Responses against self antigens are termed autoimmunity, and disorders caused by such responses are called autoimmune diseases. This chapter describes the important features of hypersensitivity reactions and the resulting diseases, focusing on their pathogenesis. Their clinicopathologic features are described only briefly and can be found in other medical textbooks. The following questions are addressed: • What are the mechanisms of different types of hypersensitivity reactions? • What are the major clinical and pathologic features of diseases caused by these reactions, and what principles underlie treatment of such diseases? Types of Hypersensitivity Reactions Hypersensitivity reactions are classified on the basis of the principal immunologic mechanism that is responsible for tissue injury and disease ( Fig.
    [Show full text]
  • IMMUNOLOGY for ANAESTHETISTS Part 2 – Hypersensitivity Reactions
    B A S I C S C I E N C E Tutorial 328 IMMUNOLOGY FOR ANAESTHETISTS Part 2 – Hypersensitivity Reactions Dr. Katharine Kennedy Anaesthetics Registrar, Mersey Deanery, UK Dr. Tushar Dixit Consultant Anaesthetist, St Helens and Knowsley NHS Trust, UK Correspondence to [email protected] th 7 APRIL 2016 QUESTIONS Before continuing, try to answer the following questions. The answers can be found at the end of the article, together with an explanation. Please answer True or False: 1. Regarding type 1 hypersensitivity reactions: a. ‘Atopic individuals’ are at higher risk of developing type I hypersensitivity reactions b. Require prior sensitisation to an antigen c. Include anaphylactic reactions d. Are mediated by IgG e. Have one phase to the reaction 2. Anaphylactoid reactions: a. Occur due to mast cell degranulation b. Are the result of IgE cross-linking on mast cells c. Are induced in all individuals exposed to anaphylactoid substances d. Are differentiated from anaphylactic reactions by the absence of mast cell tryptase e. May cause hypotension on induction of anaesthesia 3. Delayed hypersensitivity reactions are: a. Also known as type IV hypersensitivity reactions b. Occur within 2 hours of exposure to antigen c. Comprise an infiltrate of T-helper cells and macrophages d. May result in granuloma formation e. Are most commonly seen in cutaneous reactions Key Points INTRODUCTION • Hypersensitivity describes the In the first immunology tutorial tutorial we covered the basic immunology process of tissue damage secondary that would help develop an understanding of where things can go wrong; to an inflammatory reaction. these are the areas we will focus on in this tutorial.
    [Show full text]
  • Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD
    Allergy and Immunology Review Corner: Chapter 17 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD. Chapter 17: Mechanisms of Immunologic Injury Prepared by Meagan W. Shepherd, MD, Ohio State University 1. The Type I hypersensitivity reaction is mediated by which antibody? A. IgA B. IgG C. IgM D. IgE 2. Which of the following reactions is characterized by cell death which begins with the binding of antigen-specific antibody with a target cell? A. Type I hypersensitivity B. Type IIA hypersensitivity C. Type IIB hypersensitivity D. Type IIC hypersensitivity 3. Which of the following is an example of a Type IIA hypersensitivity reaction? A. Myasthenia gravis B. Graves’ disease C. Autoimmune urticaria D. Hemolytic anemia 4. Which of the following describes a Type IIC hypersensitivity reaction? A. Anaphylactic B. Antibody-mediated cytotoxic C. Antibody-mediated neutralizing D. Antibody-mediated stimulatory 5. Which of the following types of reactions characterizes an Arthrus reaction? A. Type IIIA hypersensitivity B. Type IIIB hypersensitivity C. Type IVA hypersensitivity D. Type IVB hypersensitivity 6. Which of the following types of hypersensitivity reaction does not involve humoral immunity but is largely mediated by T lymphocytes? A. Type I hypersensitivity B. Type II hypersensitivity C. Type III hypersensitivity D. Type IV hypersensitivity 7. Type IVC hypersensitivity reactions are mediated by which of the following subtypes of T cells? A. Th1 cells B. Th2 cells C. Th17 cells D. CD8+ cytotoxic cells 8. Which of the following types of reactions has granulomas as a prominent clinical feature? A. Type IVA hypersensitivity B.
    [Show full text]
  • Hypersensitivity
    HYPERSENSITIVITY HYPERSENSITIVITY undesirable (damaging, discomfort producing and sometimes fatal) reaction produced by the normal immune system • hypersensitivity reactions require a pre-sensitized (immune) state of the host HYPERSENSITIVITY Hypersensitivity reactions can be divided into four types according to Gell and Coombs: • type I, • type II, • type III • type IV, based on: • time taken for the reaction • type of antygen • the mechanisms involved • clinical symptoms Frequently, a particular clinical condition (disease) may involve more than one type of reaction. TYPE I HYPERSENSITIVITY TYPE I HYPERSENSITIVITY known also as immediate or anaphylactic hypersensitivity 15-30 minutes from the time of exposure, although sometimes may have a delayed onset (10 - 12 h) symptoms depends on the place of antigen entrance and reaction appearance - weal & flare histology - basophils and eosinophils TYPE I HYPERSENSITIVITY ANTIGEN: is soluble exogenous e.g: Drugs (antibiotics) Foods (nuts, shellfish) Insect venoms pollens Antigens enter body by: Injection Ingestion Inhalation Absorption Induces antibody formation Anaphylaxis Pathophysiology IMMUNOGLOBULIN – IgE very high affinity for its receptor on mast cells and basophils = is homocytotropic IMMUNE CELLs Mast cells In all subcutaneous/submucosal tissues, Including conjunctiva, upper/lower respiratory tracts, and gut Basophils Circulate in blood mechanisms: Subsequent exposure to the same allergen cross links the cell-bound IgE and triggers the release of various pharmacologically
    [Show full text]
  • Hypersensitivity.Pdf
    HYPERSENSITIVITY RAKESH SHARDA Department of Veterinary Microbiology NDVSU College of Veterinary Science & A.H., MHOW INTRODUCTION • Hypersensitivity can be defined as a state of altered immune response against an antigen characterized by hyper reactivity leading to immunopathology • Hypersensitivity reactions require a pre-sensitized (immune) state of the host. • There are two categories of adaptive hypersensitivities: –Immediate hypersensitivities refer to humoral immunity (antigen/antibody reactions) –Delayed hypersensitivities refer to cell-mediated immunity(cytotoxic T-lymphocytes, macrophages, and cytokines) CLASSIFICATION OF HYPERSENSITIVITY Coomb and Gell in 1963 classified hypersensitivity reactions into the following four types based on the mechanism involved and time taken for the reaction. Type I Hypersensitivity (IgE mediated anaphylactic hypersensitivity) Characteristics of Type-I hypersensitivity • It is also known as immediate or anaphylactic hypersensitivity and is mediated by IgE. • The reaction occurs on exposure to allergen second time. The first exposure (sensitizing dose) results in sensitization of host to allergen and subsequent exposure (s) (shocking dose) will cause reaction • Anaphylactic shock occurs in sensitized animals within seconds to minutes (15-30after exposure to the allergen) after exposure to the antigen, now called as an allergen. Sometimes the reaction may have a delayed onset (10-12 hours). • In type I hypersensitivity reactions, the allergens are proteins with a molecular weight ranging from 10 to 40 kDa. • Diagnostic tests for immediate hypersensitivity include skin (prick and intradermal) tests resulting in wheal and flare reaction, measurement of total IgE and specific IgE antibodies against the suspected allergens by ELISA, Radioallergosorbent test (RAST) Mechanism of Type-I hypersensitivity • The mechanism of reaction involves preferential production of IgE, in response to certain antigens (allergens).
    [Show full text]